Ironwood IPO Raises Plenty Of Cash And Plenty Of Questions For Biotech Investors
This article was originally published in The Pink Sheet Daily
Executive Summary
The much-anticipated debut of the constipation-drug developer hits $188 million, but a venture owner had to buy nearly half the issue.